NO991425D0 - Medisinsk behandling - Google Patents

Medisinsk behandling

Info

Publication number
NO991425D0
NO991425D0 NO991425A NO991425A NO991425D0 NO 991425 D0 NO991425 D0 NO 991425D0 NO 991425 A NO991425 A NO 991425A NO 991425 A NO991425 A NO 991425A NO 991425 D0 NO991425 D0 NO 991425D0
Authority
NO
Norway
Prior art keywords
pct
sec
date
humans
medical treatment
Prior art date
Application number
NO991425A
Other languages
English (en)
Norwegian (no)
Other versions
NO991425L (no
Inventor
Peter Finian Kelly
Stephen Paul Jones
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of NO991425L publication Critical patent/NO991425L/no
Publication of NO991425D0 publication Critical patent/NO991425D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
NO991425A 1996-09-25 1999-03-24 Medisinsk behandling NO991425D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9619962.5A GB9619962D0 (en) 1996-09-25 1996-09-25 Medical treatment
PCT/EP1997/005034 WO1998013033A1 (en) 1996-09-25 1997-09-15 Medical treatment

Publications (2)

Publication Number Publication Date
NO991425L NO991425L (no) 1999-03-24
NO991425D0 true NO991425D0 (no) 1999-03-24

Family

ID=10800448

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991425A NO991425D0 (no) 1996-09-25 1999-03-24 Medisinsk behandling

Country Status (26)

Country Link
US (1) US6162831A (sk)
EP (1) EP1007023B1 (sk)
JP (1) JP2001501608A (sk)
KR (1) KR20000048568A (sk)
CN (1) CN1231604A (sk)
AT (1) ATE239460T1 (sk)
AU (1) AU722129B2 (sk)
BG (1) BG103278A (sk)
BR (1) BR9711414A (sk)
CA (1) CA2266438A1 (sk)
DE (1) DE69721838T2 (sk)
DK (1) DK1007023T3 (sk)
ES (1) ES2199374T3 (sk)
GB (1) GB9619962D0 (sk)
HR (1) HRP970519A2 (sk)
HU (1) HUP9904545A3 (sk)
IL (1) IL128851A (sk)
NO (1) NO991425D0 (sk)
NZ (1) NZ334668A (sk)
PL (1) PL332423A1 (sk)
PT (1) PT1007023E (sk)
SK (1) SK32199A3 (sk)
TR (1) TR199900649T2 (sk)
TW (1) TW415842B (sk)
WO (1) WO1998013033A1 (sk)
ZA (1) ZA978573B (sk)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6339106B1 (en) 1999-08-11 2002-01-15 Sepracor, Inc. Methods and compositions for the treatment and prevention of sexual dysfunction
US6476078B2 (en) 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US6974838B2 (en) 1998-08-24 2005-12-13 Sepracor Inc. Methods of treating or preventing pain using sibutramine metabolites
US6331571B1 (en) 1998-08-24 2001-12-18 Sepracor, Inc. Methods of treating and preventing attention deficit disorders
TR200102699T2 (tr) * 1999-03-19 2002-03-21 Knoll Gmbh Kronik mafsal bozukluĞunun (osteoarthritis) tedavisi
US6552087B1 (en) 1999-03-19 2003-04-22 Abbott Gmbh & Co. Kg Therapeutic agent comprising (+)-sibutramine
US6399826B1 (en) 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
WO2002083631A1 (en) 2001-04-13 2002-10-24 Sepracor Inc. Methods of preparing didesmethylsibutramine and other sibutramine derivatives
US11103542B2 (en) 2002-03-13 2021-08-31 Kibow Biotech, Inc. Composition and method for maintaining healthy kidney function
US9655932B2 (en) * 2002-03-13 2017-05-23 Kibow Biotech, Inc. Composition and method for preventing or treating gout or hyperuricemia
BR0315084A (pt) * 2002-10-05 2005-08-16 Hanmi Pharm Ind Co Ltd Composição farmacêutica compreendendo hemiidrato cristalino de metanossulfonato de sibutramina
US20050131074A1 (en) * 2003-08-04 2005-06-16 Beckman Kristen M. Methods for treating metabolic syndrome
WO2006012438A2 (en) * 2004-07-21 2006-02-02 University Of Florida Research Foundation, Inc. Compositions and methods for treatment and prevention of insulin resistance
KR100627687B1 (ko) * 2005-04-20 2006-09-25 주식회사 씨티씨바이오 시부트라민 유리염기 함유 조성물 및 이의 제조방법
CN101528265A (zh) * 2006-11-22 2009-09-09 Sk化学株式会社 西布曲明和β-环糊精的包络物
US11179426B2 (en) 2016-12-29 2021-11-23 Kibow Biotech, Inc. Composition and method for maintaining healthy kidney function
AU2019370565A1 (en) * 2018-11-02 2021-06-24 Ampersand Biopharmaceuticals, Inc. Management of risk of cation overload and electrolyte imbalance with topically applied buffers

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52768B1 (en) * 1981-04-06 1988-02-17 Boots Co Ltd 1-arylcyclobutylalkylamine compounds useful as therapeutic agents
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
GB8704777D0 (en) * 1987-02-28 1987-04-01 Boots Co Plc Medical treatment
JP2675573B2 (ja) * 1988-03-31 1997-11-12 科研製薬株式会社 脳機能改善剤
IE61928B1 (en) * 1988-11-29 1994-11-30 Boots Co Plc Treatment of obesity
EP0708639A4 (en) * 1992-06-23 1997-08-20 Sepracor Inc METHOD AND COMPOSITIONS FOR TREATMENT OF DEPRESSION AND OTHER DISEASES USING OPTICALLY PURE SIBUTTRAMINE
AU4542893A (en) * 1992-06-23 1994-01-24 Sepracor, Inc. Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment

Also Published As

Publication number Publication date
TW415842B (en) 2000-12-21
BR9711414A (pt) 2000-04-25
NZ334668A (en) 2000-07-28
DK1007023T3 (da) 2003-08-25
AU722129B2 (en) 2000-07-20
DE69721838T2 (de) 2004-01-22
KR20000048568A (ko) 2000-07-25
EP1007023A1 (en) 2000-06-14
NO991425L (no) 1999-03-24
JP2001501608A (ja) 2001-02-06
AU4385197A (en) 1998-04-17
HUP9904545A3 (en) 2000-12-28
CN1231604A (zh) 1999-10-13
IL128851A0 (en) 2000-01-31
EP1007023B1 (en) 2003-05-07
ATE239460T1 (de) 2003-05-15
PL332423A1 (en) 1999-09-13
SK32199A3 (en) 1999-12-10
US6162831A (en) 2000-12-19
ES2199374T3 (es) 2004-02-16
CA2266438A1 (en) 1998-04-02
GB9619962D0 (en) 1996-11-13
BG103278A (en) 2000-01-31
HUP9904545A2 (hu) 2000-11-28
DE69721838D1 (de) 2003-06-12
WO1998013033A1 (en) 1998-04-02
IL128851A (en) 2001-08-26
ZA978573B (en) 1999-03-25
TR199900649T2 (xx) 1999-07-21
PT1007023E (pt) 2003-08-29
HRP970519A2 (en) 1998-08-31

Similar Documents

Publication Publication Date Title
NO991425D0 (no) Medisinsk behandling
DE60039508D1 (de) Methoden zur behandlung der essstörungen
ZA95814B (en) Medical treatment
LU90956I2 (fr) Metvix principe actif méthylaminolevulinique sous forme d'un selde préférence l'hyhrochlorure méthylaminolevulinique
NO971471L (no) Nye karboksamider med fungicid aktivitet
IL177626A0 (en) Pharmaceutical compositions for treating sleep apnoea
DE60220055D1 (de) 4-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)harnstoff und dessen verwendung bei der behandlung von mit glycogensynthasekinase-3 (gsk3) assoziierten leiden
WO2000056315A8 (en) Treatment of pain
MXPA01009467A (es) Metodo para controlar el aumento de peso asociado con farmacos terapeuticos.
KR970706811A (ko) I형 알레르기성 질환의 예방 및 치료제(Preventive and remedy for type Ⅰ allergic diseases)
MXPA01009468A (es) Tratamiento de hipertension pulmonar.
MXPA01009461A (es) Tratamiento de osteoartritis.
BG106000A (en) Treatment of hiatial hernia
KR950016739A (ko) 강박관념 질환 및 소모성 질환을 억제하는 방법
NO20013464L (no) Anvendelse av 3-isoksazolidinoner og hydroksylaminsyrer for behandling av infeksjoner
RU99108729A (ru) Способ лечения
RU2001126350A (ru) Применение фторированных триазолов для лечения боли и аффективных нарушений и нарушений внимания
TH18470A (th) อนุพันธ์เมลาโทนินสำหรับใช้ในการรักษาความผิดปกติของการหลับ
MXPA01009462A (es) Tratamiento de calculos biliares.
MXPA01009465A (es) Perdida de peso despues del embarazo.